---
document_datetime: 2023-09-21 17:57:40
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/karvea-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: karvea-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 4.3080994
conversion_datetime: 2025-12-15 01:52:29.903019
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Steps taken after granting the Marketing Authorisation

## For procedures finalised after 1 September 2004 please refer to module 8B.

- The Marketing Authorisation Holder submitted to the EMEA on 28 August 1997 an application for three type I variations falling within the scope of item No. 11 and item No. 16 of Annex I to Commission Regulation (EC) No 542/95. The Marketing Authorisation Holder applied for:
1. Change in the manufacturers involved in the manufacture of the active substance, i.e. the addition of another manufacturer, Omnichem N.V. (Belgium).
2. Change in the manufacturers involved in the manufacture of the active substance, i.e. the addition of another manufacturer, Squibb Manufacturing Inc. (Puerto Rico).
3. Increase in the granulation batch size for the finished product intended for marketing.

On  4  September  1997,  the  EMEA  approved  the  variations.  These  variations  did  not  require amendments to the Commission Decision.

- The  Marketing  Authorisation  Holder  submitted  to  the  EMEA  on  10  September  1997  an application  for  one  type  I  variation  falling  within  the  scope  of  item  No.  11  of  Annex  I  to Commission Regulation (EC) No 542/95. The Marketing Authorisation Holder applied for:

Change  in  the  manufacturers  involved  in  the  manufacture  of  the  active  substance,  i.e.  the addition of another manufacturer, Orgamol SA (Switzerland).

On  17  October  1997,  the  EMEA  approved  the  variation.  This  variation  did  not  require amendments to the Commission Decision.

- The Marketing Authorisation Holder submitted to the EMEA on 12 January 1998 an application for  one  type  I  variation  falling  within  the  scope  of  item  No  12  of  Annex  I  to  Commission Regulation (EC) No 542/95. The Marketing Authorisation Holder applied for:

A minor change of the manufacturing process of the active substance

On  20  February  1998,  the  EMEA  approved  the  variation.  This  variation  did  not  require amendments to the Commission Decision.

- The Marketing Authorisation Holder submitted to the EMEA on 08 June 1998 an application for  one  type  I  variation  falling  within  the  scope  of  item  No  11  of  Annex  I  to  Commission Regulation (EC) No 542/95, as amended. The Marketing Authorisation Holder applied for:

An alternative manufacturer for the active substance.

On  07  August  1998,  the  EMEA  approved  the  variation.  This  variation  did  not  require amendments to the Commission Decision.

- The  Marketing  Authorisation  Holder  submitted  to  the  EMEA  on  22  September  1998  an application  for  one  type  I  variation  falling  within  the  scope  of  item  No  15  of  Annex  I  to Commission  Regulation  (EC)  No  542/95,  as  amended.  The  Marketing  Authorisation  Holder applied for:

A  change  in  the  manufacture  of  the  medicinal  product,  specifically  an  alternative  powder transferring process.

On  23  October  1998,  the  EMEA  approved  the  variation.  This  variation  did  not  require amendments to the Commission Decision.

- Âƒ On  25  September  1998  The  Marketing  Authorisation  Holder  submitted  a  Type  II  variation application  in  accordance  with  Article  6  of  Commission  Regulation  (EC)  No.  542/95  of  10 March 1995, as amended. The scope of the variation related to the update in the SPC and PL according  to  the  irbesartan-specific  information  provided  in  the  CoAprovel  positive  opinion. The wording of the legal status has also been updated in Annex II of the Commission decision.

On 17 December 1998 the CPMP approved the variation. The variation required amendments in the relevant sections of the Commission Decision and the EPAR. The European Commission

<div style=\"page-break-after: always\"></div>

amended the Decision on 13 April 1999 . In addition, the scientific discussion on efficacy of the EPAR was updated with more detailed information.

- The  Marketing  Authorisation  Holder  submitted  to  the  EMEA  on  18  December  1998  an application  for  one  type  I  variation  falling  within  the  scope  of  item  No  11b  of  Annex  I  to Commission  Regulation  (EC)  No  542/95,  as  amended.  The  Marketing  Authorisation  Holder applied for:

An alternative manufacturer for one step of the manufacturing process of the active substance.

On 20 January 1999, the EMEA approved the variation. This variation did not require amendments to the Commission Decision.

- The Marketing Authorisation Holder submitted to the EMEA on 24 March 1999 an application for  one  type  I  variation  falling  within  the  scope  of  item  No  1  of  Annex  I  to  Commission Regulation (EC) No 542/95, as amended. The Marketing Authorisation Holder applied for:

An authorisation of a second European site responsible for batch release for the EU.

On  28  April  1999,  the  EMEA  issued  the  corresponding  notification.  This  variation  required amendments to the Commission Decision. The respective Commission Decision was issued on 16 June 1999.

- The Marketing Authorisation Holder submitted to the EMEA 26 April 1999 an application for one  type  I  variation  falling  within  the  scope  of  item  No  12a  of  Annex  I  to  Commission Regulation (EC) No 542/95, as amended. The Marketing Authorisation Holder applied for:

Changes in the specification of starting material used in the manufacture of the active substance.

On 1 June 1999, the EMEA issued the corresponding notification. This variation did not require amendments to the Commission Decision.

- The Marketing Authorisation Holder submitted to the EMEA 5 August 1999 an application for one  type  I  variation  falling  within  the  scope  of  item  No  11b  of  Annex  I  to  Commission Regulation (EC) No 542/95, as amended. The Marketing Authorisation Holder applied for:

An  alternative  supplier  of  an  intermediate  compound  used  in  the  manufacture  of  the  active substance.

On 8 September 1999, the EMEA issued the corresponding notification. This variation did not require amendments to the Commission Decision.

- On  8  September  1999  The  Marketing  Authorisation  Holder  submitted  a  Type  II  variation application  in  accordance  with  Article  6  of  Commission  Regulation  (EC)  No.  542/95  of  10 March 1995, as amended. The scope of the variation related to the update in the SPC and PL according  to  the  irbesartan  post-marketing  experience  and  new  pharmacokinetic  data.  In addition,  on  3  December  1999,  the  MAH  applied  for  changes  of  the  Representative  of  the Aprovel Marketing Authorisation Holder following the merger of Sanofi and Synthelabo.

On 16 December 1999 the CPMP approved the variation. The variation required amendments in the relevant sections of the Commission Decision and the EPAR. The European Commission amended the Decision on 3 May 2000 .

- The Marketing Authorisation Holder submitted to the EMEA 19 November 1999 an application for  one  type  I  variation  falling  within  the  scope  of  item  No  12  of  Annex  I  to  Commission Regulation (EC) No 542/95, as amended. The Marketing Authorisation Holder applied for:

A minor change in the manufacturing process of the active substance.

On 21 December 1999, the EMEA issued the corresponding notification. This variation did not require amendments to the Commission Decision.

<div style=\"page-break-after: always\"></div>

Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below:

| Scope                                                                                                                                | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amended on   |
|--------------------------------------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|-----------------------------------------|
| Minor change in labelling or package leaflet not connected with the SPC (Art. 10.3 Notification)                                     | N/0016               | N                        | 20.06.00                            | 27.07.00                                |
| Update of Summary of Product Characteristics and Package Leaflet The SPC was updated following the assessment of the 4 th PSUR.      | II/0017              | II                       | 27.07.00                            | 16.11.00                                |
| Extension of shelf-life as foreseen at time of authorisation                                                                         | I/0018               | I                        | 26.10.00                            | 15.01.01                                |
| Change in test procedure for starting material/intermediate used in manuf. of active substance                                       | I/0019               | I                        | 21.11.00                            | N/A                                     |
| Update of Summary of Product Characteristics and Package Leaflet The SPC was updated regarding the information in case of pregnancy. | II/0020              | II                       | 14.12.00                            | 23.04.01                                |
| Changes to comply with supplements to pharmacopoeias                                                                                 | I/0021               | I                        | 20.03.01                            | 26.03.01                                |
| Minor change of manufacturing process of the active substance                                                                        | I/0022               | I                        | 26.04.01                            | 02.05.01                                |
| Update of the SPC and PL (Point 4.5, 4.8, 6.5)                                                                                       | I/0023               | I                        | 20.09.01                            | 10.04.02                                |
| Change in pack size for a medicinal product                                                                                          | I/0024               | I                        | 13.07.01                            | 08.10.01                                |
| Change in pack size for a medicinal product                                                                                          | I/0025               | I                        | 13.07.01                            | 08.10.01                                |
| Change in pack size for a medicinal product                                                                                          | I/0026               | I                        | 13.07.01                            | 08.10.01                                |
| Change in pack size for a medicinal product                                                                                          | I/0027               | I                        | 20.09.01                            | --                                      |
| Change in pack size for a medicinal product                                                                                          | I/0028               | I                        | 20.09.01                            | --                                      |
| Extension of the Indication                                                                                                          | II/0029              | II                       | 21.02.02                            | 12.06.02                                |
| Change in pack size for a medicinal product                                                                                          | I/0030               | I                        | 20.09.01                            | 19.02.02                                |
| Change in the name and/or address of the marketing authorisation holder                                                              | I/0031               | I                        | 20.09.01                            | --                                      |
| Replacement of an excipient with a comparable excipient                                                                              | I/0032               | I                        | 12.10.01                            |                                         |
| Change in the manufacturing authorisation                                                                                            | I/0033               | I                        | 11.01.02                            | 12.04.02                                |
| Change in batch size of finished product                                                                                             | I/0034               | I                        | 26.11.01                            |                                         |
| Change in the manufacturing authorisation                                                                                            | I/0035               | I                        | 22.12.01                            | 08.03.02                                |
| Change in test procedure for starting material/intermediate used in manufacturing of active substance                                | I/0036               | I                        | 10.04.02                            | 02.05.02                                |
| Change in test procedure for starting material/intermediate used in manufacturing of active substance                                | I/0037               | I                        | 10.04.02                            | 30.04.02                                |
| Renewal                                                                                                                              | R/0038               | R                        | 25.07.02                            | 29.10.02                                |
| Changes in manufacture of the medicinal product                                                                                      | I/0039               | I                        | 05.06.02                            | 18.06.02                                |
| Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3) Notification                                     | N/0040               | N                        | 07.06.02                            | 28.06.02                                |
| Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                     | N/0041               | N                        | 03.12.02                            | 16.01.03                                |

1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.

<div style=\"page-break-after: always\"></div>

<!-- image -->

| Minor change of manufacturing process of active substance                                                                                                               | I/0042   | I   | 07.06.02   | 28.06.02   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------|-----|------------|------------|
| Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                        | N/0043   | N   | 17.01.03   | 07.03.03   |
| Update of Summary of Product Characteristics and Package Leaflet                                                                                                        | II/0044  | II  | 25.04.03   | 30.07.03   |
| Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                        | N/0045   | N   | 04.04.03   | 19.05.03   |
| Extension of shelf-life or retest period of the active substance                                                                                                        | I/0046   | I   | 21.03.03   | 01.04.03   |
| Change in or addition of manufacturer(s) of active substance                                                                                                            | I/0047   | I   | 23.04.03   | 25.04.03   |
| Minor change of manufacturing process of the active substance                                                                                                           | I/0048   | I   | 12.06.03   | 19.06.03   |
| Minor change of manufacturing process of the active substance                                                                                                           | I/0049   | I   | 12.06.03   | -          |
| Change or addition of a new pharmaceutical form                                                                                                                         | X/0050   | X   | 22.10.03   | 02.03.04   |
| Change in supplier of an intermediate compound used in manufacture of the active substance                                                                              | I/0051   | I   | 31.10.03   | 12.11.03   |
| Minor change in the manufacturing process of the active substance                                                                                                       | I/0052   | I   | 10.11.03   | -          |
| Change in BR/QC testing - repl./add. of batch control/testing site and replacement/addition of manufacturing site: All other manufacturing operations ex. batch release | IB/0053  | IB  | 23.12.03   | -          |
| Change in manuf. of active substance without Ph. Eur. certificate - change in manuf. site                                                                               | IB/0054  | IB  | 14.04.04   | -          |
| Update of Summary of Product Characteristics, Labelling and Package Leaflet                                                                                             | II/0055  | II  | 03.06.04   | 02.08.04   |
| Minor change in the manufacturing process of the active substance                                                                                                       | IB/0056  | IB  | 01.07.04   | -          |
| Change in BR/QC testing - repl./add. manuf. responsible for BR - not incl. BC/testing                                                                                   | IA/0057  | IA  | 30.06.04   | -          |
| Replacement/addition of manufacturing site: Secondary packaging site and change in BR/QC testing - repl./add. manuf. responsible for BR - not incl. BC/testing          | IA/0058  | IA  | 30.06.04   | -          |
| Change in manuf. of active substance without Ph. Eur. certificate - change in manuf. site                                                                               | IB/0059  | IB  | 28.07.04   | -          |
| Change in manuf. of active substance without Ph. Eur. certificate - change in manuf. site                                                                               | IB/0060  | IB  | 29.07.04   | -          |
| Minor change in the manufacturing process of the active substance                                                                                                       | IB/0061  | IB  | 10.08.04   | -          |